In this study, we demonstrated that treatment with an ADORA3 antagonist provides a renoprotective effect during the early stages of kidney damage in STZ-induced diabetic rats by decreasing the proinflammatory cytokines IL-1β and IL18. The gene discussed is IL18; the disease is Nephropathy.